These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20410597)

  • 61. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Paramar AN; Balaraman R
    Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Lipopolysaccharide of Helicobacter pylori protects gastric mucosa via generation of nitric oxide.
    Brzozowski T; Konturek PC; Sliwowski Z; Drozdowicz D; Pajdo R; Stachura J; Hahn EG; Konturek SJ
    J Physiol Pharmacol; 1997 Dec; 48(4):699-717. PubMed ID: 9444618
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ginsenoside Rb1 improves cardiac function and remodeling in heart failure.
    Zheng X; Wang S; Zou X; Jing Y; Yang R; Li S; Wang F
    Exp Anim; 2017 Aug; 66(3):217-228. PubMed ID: 28367863
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibitory effect of ginsenoside Rb1 on cardiac hypertrophy induced by monocrotaline in rat.
    Jiang QS; Huang XN; Dai ZK; Yang GZ; Zhou QX; Shi JS; Wu Q
    J Ethnopharmacol; 2007 May; 111(3):567-72. PubMed ID: 17374466
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension : novel molecular adaptation to systolic load in absence of hypertrophy.
    Bartunek J; Weinberg EO; Tajima M; Rohrbach S; Katz SE; Douglas PS; Lorell BH
    Circulation; 2000 Feb; 101(4):423-9. PubMed ID: 10653835
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Spontaneous, L-arginine-induced and spironolactone-induced regression of protein remodeling of the left ventricle in L-NAME-induced hypertension.
    Simko F; Potácová A; Pelouch V; Paulis L; Matúsková J; Krajcírovicová K; Pechánová O; Adamcová M
    Physiol Res; 2007; 56 Suppl 2():S55-S62. PubMed ID: 17824806
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of nitric oxide in the progression of cardiovascular remodeling induced by carotid arterio-venous shunt in rabbits.
    Miyamoto T; Takeishi Y; Shishido T; Takahashi H; Itoh M; Kubota I; Tomoike H
    Jpn Heart J; 2003 Jan; 44(1):127-37. PubMed ID: 12622444
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chronic administration of angiotensin-(1-7) attenuates pressure-overload left ventricular hypertrophy and fibrosis in rats.
    Wang LJ; He JG; Ma H; Cai YM; Liao XX; Zeng WT; Liu J; Wang LC
    Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):481-7. PubMed ID: 15897115
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiac and renal effects of growth hormone in volume overload-induced heart failure: role of NO.
    Pagel I; Langenickel T; Höhnel K; Philipp S; Nüssler AK; Blum WF; Aubert ML; Dietz R; Willenbrock R
    Hypertension; 2002 Jan; 39(1):57-62. PubMed ID: 11799079
    [TBL] [Abstract][Full Text] [Related]  

  • 71. l-Arginine Attenuates Cardiac Dysfunction, But Further Down-Regulates α-Myosin Heavy Chain Expression in Isoproterenol-Induced Cardiomyopathy.
    Kralova E; Doka G; Pivackova L; Srankova J; Kuracinova K; Janega P; Babal P; Klimas J; Krenek P
    Basic Clin Pharmacol Toxicol; 2015 Oct; 117(4):251-60. PubMed ID: 25865156
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Chronic (-)-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Romero M; O'Valle F; Lopez-Sepulveda R; Quintela AM; Galindo P; Zarzuelo MJ; Bailón E; Delpón E; Perez-Vizcaino F; Duarte J
    Br J Nutr; 2011 Nov; 106(9):1337-48. PubMed ID: 21910946
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production.
    Ogawa T; Linz W; Stevenson M; Bruneau BG; Kuroski de Bold ML; Chen JH; Eid H; Schölkens BA; de Bold AJ
    Circulation; 1996 Jun; 93(11):2059-67. PubMed ID: 8640983
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enhanced expression of endothelial nitric oxide synthase in the myocardium ameliorates the progression of left ventricular hypertrophy in L-arginine treated Wistar-Kyoto rats.
    Ahmad A; Sattar MA; Rathore HA; Abdulla MH; Khan SA; Abdullah NA; Johns EJ
    J Physiol Pharmacol; 2016 Feb; 67(1):31-44. PubMed ID: 27010893
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of hydroxymethylglutaryl coenzyme a reductase inhibition on left ventricular remodeling after myocardial infarction: an experimental serial cardiac magnetic resonance imaging study.
    Nahrendorf M; Hu K; Hiller KH; Galuppo P; Fraccarollo D; Schweizer G; Haase A; Ertl G; Bauer WR; Bauersachs J
    J Am Coll Cardiol; 2002 Nov; 40(9):1695-700. PubMed ID: 12427425
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Ventricular hypertrophy and arterial hemodynamics following deprivation of nitric oxide in rats.
    Hu CT; Chang HR; Hsu YH; Liu CJ; Chen HI
    Life Sci; 2005 Nov; 78(2):164-73. PubMed ID: 16125730
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Study on roles of L-arginine to nitric oxide pathway for the cardiovascular control: assessment with a new model of hypertension produced by the chronic administration of nitric oxide synthase inhibitor].
    Shudo H
    Hokkaido Igaku Zasshi; 1994 Jul; 69(4):967-77. PubMed ID: 7525439
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Chronic NG-nitro-l-arginine methyl ester (L-NAME) administration in C57BL/6J mice induces a sustained decrease in c-kit positive cells during development of cardiac hypertrophy.
    Ocsan RJ; Lai YN; Prabhu KV; Hambly BD; McLachlan CS
    J Physiol Pharmacol; 2013 Dec; 64(6):727-36. PubMed ID: 24388887
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Interaction between hydrogen sulfide and nitric oxide on cardiac protection in rats with metabolic syndrome.
    Rong-na L; Xiang-jun Z; Yu-han C; Ling-qiao L; Gang H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb; 33(1):25-32. PubMed ID: 21375934
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN; Zhou ZM; Chen P
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):211-6. PubMed ID: 17941891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.